Stephen Poor
Executive Director of Translational Development
Apellis Pharmaceuticals
Biography
Physician scientist (UK trained ophthalmologist) with over 20 years drug discovery and development experience.
Current role is Head of Translational Medicine at Apellis. Broad responsibilities include clinical trial leadership for GA and Alzheimer’s programs, BD&L, end-point strategy, clinical trial optimization and technology innovation.
Previous roles @ Novartis include Head of Retinal Pharmacology, Director External Innovation and Global Program Clinical Head for Ophthalmology.